How to Calculate Cost Savings From Buying Larger Tesamorelin Vials

Figuring out how to calculate cost savings from buying larger tesamorelin vials comes down to one conversion: turning a vial’s list price into a price per milligram, then comparing that figure across the vial sizes a listing offers. A larger vial almost always carries a lower per-milligram cost, but the size of that discount varies enough between suppliers that the sticker price alone is not a reliable guide.

Why Vial Size Changes the Math

A tesamorelin listing is priced per vial, and each vial states a total peptide mass in milligrams. A 2 mg vial and a 10 mg vial are not the same product scaled up by a fixed multiple — the larger vial usually costs less per milligram because packaging, labeling, and handling costs are spread across more peptide mass. That means the listed price ratio between two vial sizes is rarely identical to the ratio of their mg content. Comparing raw prices (“the 10 mg vial costs three times as much as the 2 mg vial”) tells you nothing about savings until it is converted to a common unit.

The Per-Milligram Formula

The calculation itself has one step:

Price per mg = Vial price ÷ Vial mg content

Once every vial size on a listing has been converted to a price per mg, they can be compared directly, and the percentage saved by choosing the larger size is:

Savings % = (1 − [larger vial price/mg ÷ smaller vial price/mg]) × 100

Worked Example

Suppose a listing quotes a 2 mg vial at $60 and a 10 mg vial at $220.

• 2 mg vial: $60 ÷ 2 mg = $30.00 per mg
• 10 mg vial: $220 ÷ 10 mg = $22.00 per mg

Checking that second calculation again: $220 divided by 10 is $22.00 per mg, confirmed.

The savings percentage from choosing the 10 mg vial:

• $22.00 ÷ $30.00 = 0.7333
• 1 − 0.7333 = 0.2667
• 0.2667 × 100 = 26.67%

So the 10 mg vial in this example is about 26.7% cheaper per milligram than the 2 mg vial. Re-running the same three steps a second time gives the identical 26.67%, which is the kind of double-check worth doing before trusting a number enough to compare across listings.

Comparison Table

Vial size	Vial price	Price per mg	Savings vs. smallest vial
2 mg	$60	$30.00/mg	— (baseline)
5 mg	$135	$27.00/mg	10.0%
10 mg	$220	$22.00/mg	26.7%

This table uses one hypothetical listing’s numbers to illustrate the pattern; actual figures vary by supplier, by revision date, and by whether a listing bundles diluent or shipping into the vial price.

Reading the Listing Correctly Before Comparing

A price-per-mg comparison is only as good as the inputs behind it, and a few details commonly get overlooked:

• Confirm the mg figure is peptide content, not total vial volume. Some listings state a fill volume in mL alongside the mg amount; the calculation above uses mg, not mL.
• Check whether the listed price includes bacteriostatic water, shipping, or handling fees, since a vial-only price and an all-in price are not comparable without adjustment.
• Note the listing’s revision date. Peptide pricing pages change periodically, and a stale cached price will distort the per-mg figure even if the arithmetic is correct.
• Watch for volume-discount pricing on multi-vial purchases, which is a separate mechanism from vial-size pricing and should not be mixed into the same calculation.

Tracking these details is easier when figures are pulled from a listing that documents revision dates rather than a page with no visible update history, which is one reason research-reference pricing tables list a “last updated” note next to each entry — a habit also seen on peer tesamorelin listing catalogs when comparing tesamorelin listings across sources.

Why the Discount Curve Flattens

The percentage saved does not increase in a straight line as vial size grows. In the table above, moving from 2 mg to 5 mg saved 10.0%, but moving from 5 mg to 10 mg only added another 16.7 percentage points despite the vial being twice as large again. This flattening happens because fixed costs — the portion of a vial’s price that does not scale with peptide mass, such as the vial itself, the stopper, and labeling — become a shrinking fraction of the total price as mg content rises. Past a certain vial size, the per-mg price tends to plateau, and buying even larger vials stops producing proportional savings.

Applying This to Research Budgeting

For anyone tracking a research budget across multiple vial purchases, the practical approach is to build a small running table: vial size, listed price, calculated price per mg, and the date the price was recorded. Updating that table each time a listing is checked turns “which size is the better deal” from a guess into a documented calculation, and it also makes it obvious when a listing’s per-mg price has drifted since the last check — something a single point-in-time comparison would miss. Cross-checking figures against a HEEZ Research before treating a listed concentration as fixed can also help confirm the mg content used in the denominator is accurate, since the savings formula is only as reliable as the mg figure fed into it.

Where Sourcing Fits Into the Comparison

Price-per-mg math assumes the vial actually contains the labeled amount, which is a sourcing question rather than an arithmetic one. Reviewing a certificate of analysis alongside the listing price — and comparing figures across more than one supplier, such as peer tesamorelin listing catalogs — helps confirm that a lower per-mg price is not offset by a lower actual concentration.

Summary

Calculating cost savings from larger tesamorelin vials means converting every vial size to a price per milligram, comparing those figures directly, and expressing the difference as a percentage using the two formulas above. The savings tend to be real but non-linear: larger vials typically cost less per mg, with the biggest percentage jump usually appearing at the first size increase and smaller gains at each size after that. Recording vial size, price, calculated price per mg, and the listing’s revision date turns this into a repeatable check rather than a one-off estimate.